The objective of this study was to determine feasibility of transferring a validated liquid-liquid extraction method to a supported liquid extraction method using Biotage ISOLUTE® SLE+ 96-well plates (400µL sample capacity). The laboratory supporting this study processes ~550 samples per month supporting vitamin D analysis in plasma and serum (mixed samples / not separated). During this evaluation, it was determined that sample processing time was reduced by ~50% for a de-identified patient set (n=30, split and processed by both methods). Towards high throughput analysis platforms, ISOLUTE SLE+ was demonstrated as a viable solution in the sample preparation workflow for vitamin D applications.
Figure 1: Vitamin D structures
The strategy for this development workflow began with the liquid-liquid extraction procedure and the direct transfer to supported liquid extraction was evaluated. To optimize the method for analyte recovery, pH adjustment was evaluated in the sample pre-treatment. Elution volumes were also optimized for analyte recovery. Once optimized, the proof-of-concept was determined on a real patient sample set. The samples were split and process by each method for verification.
Internal standard d6-25-hydroxyvitamin D2, d3-25-hydroxyvitamin D3. 200 ng/mL in MeOH
Sample pre-treatment mix (SLE) 5M NaOH/H2O/IPA (50:50:100, v/v/v)
Aqueous mobile phase 2 mM ammonium acetate, 0.1% formic acid in H2O
Methanol mobile phase 2 mM ammonium acetate, 0.1% formic acid in MeOH
Waters Quattro Micro triple quadrupole tandem mass spectrometer
Electrospray source (+)
Agilent 1100 or Waters 2795 Alliance HT HPLC
Phenomenex Kinetex 2.6 µm PFP 100A
100 mm x 3 mm
Phenomenex Security Guard ULTRA cartridges
UHPLC PFP for 3.0mm ID columns
Security Guard ULTRA holder
|
Pump |
Flow (mL/min) 0.5 Run time (min) 10.0 |
|
Time (min) |
Mobile phase A (%) |
Mobile phase B (%) |
Flow (mL/min) |
|
0.00 |
24.0 |
76.0 |
0.5 |
|
4.00 |
24.0 |
76.0 |
0.5 |
|
4.10 |
5.0 |
95.0 |
0.5 |
|
5.40 |
5.0 |
95.0 |
0.5 |
|
5.50* |
24.0 |
76.0 |
0.5 |
*The analytical window runs to 5.5 min and then the cartridge equilibrates for additional time. The total time is 10 min.
|
Source: |
ES+ |
|
Capillary (kV): |
0.4 |
|
Source temperature (°C): |
120 |
|
Desolvation temperature (°C): |
450 |
|
Collision gas (mbar): |
1.1 x 10-3 |
|
Dwell (s): |
0.2 |
|
Delay (s): |
0.1 |
|
Compound |
Type of use |
Transition |
(V) |
Collision (eV) |
|
25-(OH)D3 |
Primary |
383.3>257.2 |
28 |
18 |
|
25-(OH)D3 |
Secondary |
401.3>365.2 |
18 |
10 |
|
d3-25-(OH)D3 |
Internal std |
404.4>368.2 |
18 |
10 |
|
25-(OH)D2 |
Primary |
413.3>355.2 |
18 |
10 |
|
25-(OH)D2 |
Secondary |
395.3>269.2 |
28 |
20 |
|
D6-25-(OH)D2 |
Internal std |
419.4>355.2 |
18 |
10 |
Total time for processing 30 samples >4 hours
Total time for processing 30 samples <2 hours
Example chromatograms for samples prepared using a) original liquid-liquid extraction method and b) supported liquid extraction method are shown in Figures 2 and 3 below:
Figure 2. Example chromatogram for vitamin D metabolites extracted using original liquid-liquid extraction method.
Figure 3. Example chromatogram for vitamin D metabolites extracted using supported liquid extraction method on ISOLUTE® SLE+ plate.
Levels of Vitamin D metabolites from split samples extracted using each technique are shown in Table 3, and correlation plots for each metabolite are shown in Figures 4 and 5.
|
Patient Sample ID |
D3-Liquid Extraction ng/mL |
D3-ISOLUTE® |
Relative Error (%) |
|
1 |
14.0 |
14.0 |
0.0 |
|
2 |
13.0 |
13.4 |
-3.1 |
|
3 |
56.0 |
57.8 |
-3.2 |
|
4 |
41.0 |
46.2 |
-12.7 |
|
5 |
17.0 |
19.1 |
-12.4 |
|
6 |
20.0 |
22.6 |
-13.0 |
|
7 |
54.0 |
57.0 |
-5.6 |
|
8 |
35.0 |
35.8 |
-2.3 |
|
9 |
12.4 |
14.3 |
-15.3 |
|
10 |
17.4 |
19.3 |
-10.9 |
|
11 |
26.9 |
27.7 |
-3.0 |
|
12 |
27.1 |
30.2 |
-11.4 |
|
13 |
4.5 |
4.30 |
4.4 |
|
14 |
21.7 |
24.8 |
-14.3 |
|
15 |
15.6 |
16.6 |
-6.4 |
|
16 |
32.0 |
38.6 |
-20.6 |
|
17 |
39.0 |
42.6 |
-9.3 |
|
18 |
15.0 |
15.2 |
-1.3 |
|
19 |
15.0 |
17.4 |
-16.3 |
|
20 |
41.0 |
50.5 |
-23.1 |
|
21 |
13.0 |
14.1 |
-8.5 |
|
22 |
25.0 |
27.8 |
-11.0 |
|
23 |
13.0 |
13.4 |
-3.1 |
|
24 |
8.0 |
9.3 |
-16.3 |
|
25 |
37.0 |
40.4 |
-9.2 |
|
26 |
36.0 |
40.3 |
-11.9 |
|
27 |
18.0 |
18.5 |
-2.8 |
|
28 |
31.0 |
29.7 |
4.2 |
|
29 |
33.0 |
36.1 |
-9.4 |
|
30 |
19.0 |
18.9 |
0.5 |
|
Patient Sample ID |
D2-Liquid Extraction ng/mL |
D2-ISOLUTE® SLE+ ng/mL |
Relative Error (%) |
|
1 |
41.0 |
40.7 |
0.7 |
|
2 |
3.0 |
2.2 |
26.7 |
|
3 |
<2 |
<2 |
N/A |
|
4 |
<2 |
<2 |
N/A |
|
5 |
3.0 |
2.4 |
20.0 |
|
6 |
6.0 |
6.1 |
-1.7 |
|
7 |
<2 |
<2 |
N/A |
|
8 |
<2 |
<2 |
N/A |
|
9 |
<2 |
<2 |
N/A |
|
10 |
2.2 |
2.1 |
4.5 |
|
11 |
<2 |
<2 |
N/A |
|
12 |
<2 |
<2 |
N/A |
|
13 |
13.3 |
15.5 |
-16.5 |
|
14 |
<2 |
<2 |
N/A |
|
15 |
<2 |
<2 |
N/A |
|
16 |
<2 |
<2 |
N/A |
|
17 |
<2 |
<2 |
N/A |
|
18 |
21.0 |
20.5 |
2.5 |
|
19 |
<2 |
<2 |
N/A |
|
20 |
<2 |
<2 |
N/A |
|
21 |
<2 |
<2 |
N/A |
|
22 |
<2 |
<2 |
N/A |
|
23 |
7.0 |
5.3 |
24.3 |
|
24 |
8.0 |
6.2 |
22.5 |
|
25 |
<2 |
<2 |
N/A |
|
26 |
<2 |
<2 |
N/A |
|
27 |
4.0 |
3.1 |
22.5 |
|
28 |
3.0 |
2.6 |
13.3 |
|
29 |
3.0 |
2.4 |
20.0 |
|
30 |
6.0 |
4.6 |
23.3 |
Figure 4. Correlation plot: Split patient sample study, determination of vitamin D3 in plasma and serum
Figure 5. Correlation plot: Split patient sample study, determination of vitamin D2 in plasma and serum.
Transfer of methodology from a traditional liquid-liquid extraction method to a supported liquid extraction method was simple and straightforward, with minimal optimization required. Good correlation between measured levels of vitamin D metabolites in split samples extracted using the original validated liquid-liquid extraction method and the optimized supported liquid extraction method using ISOLUTE SLE+ plates was achieved.
Time for processing a batch of 30 patient samples (serum and plasma) was approximately halved using the supported liquid extraction approach, from > 4 hours to < 2 hours. Due to the cleaner nature of the extraction, centrifugation steps were not required in the supported liquid extraction method.
This study suggests that supported liquid extraction using ISOLUTE®SLE+ 96-well extraction plates is a viable alternative to liquid-liquid extraction in a busy clinical laboratory.
|
Part Number |
Description |
Quantity |
|
820-0400-P01 |
ISOLUTE® SLE+ 400 μL Supported Liquid Extraction Fixed Well Plate |
1 |
Literature Number: PPS367